The pathogenic yeast Candida albicans can grow in multiple morphological states including budded, pseudohyphal and true hyphal forms. The ability to interconvert between budded and hyphal forms, herein termed the budded-to-hyphal transition (BHT), is important for C. albicans virulence, and is regulated by multiple environmental and cellular signals. To identify small-molecule inhibitors of known cellular processes that can also block the BHT, a microplate-based morphological assay was used to screen the BIOMOL–Institute of Chemistry and Cell Biology (ICCB) Known Bioactives collection from the ICCB-Longwood Screening Facility (Harvard Medical School, Boston, MA, USA). Of 480 molecules tested, 53 were cytotoxic to C. albicans and 16 were able to block the BHT without inhibiting budded growth. These 16 BHT inhibitors affected protein kinases, protein phosphatases, Ras signalling pathways, G protein-coupled receptors, calcium homeostasis, nitric oxide and guanylate cyclase signalling, and apoptosis in mammalian cells. Several of these molecules were also able to inhibit filamentous growth in other Candida species, as well as the pathogenic filamentous fungus Aspergillus fumigatus, suggesting a broad fungal host range for these inhibitory molecules. Results from secondary assays, including hyphal-specific transcription and septin localization analysis, were consistent with the inhibitors affecting known BHT signalling pathways in C. albicans. Therefore, these molecules will not only be invaluable in deciphering the signalling pathways regulating the BHT, but also may serve as starting points for potential new antifungal therapeutics.
AlemM. A. S.,
DouglasL. J.2004; Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans
. Antimicrob Agents Chemother 48:41–47[CrossRef]
AriokaM.,
HirataA.,
TakatsukiA.,
YamasakiM.1991; Brefeldin A blocks an early stage of protein transport in Candida albicans
. J Gen Microbiol 137:1253–1262[CrossRef]
BarringtonR. E.,
SublerM. A.,
RandsE.,
OmerC. A.,
MillerP. J.,
HundleyJ. E.,
KoesterS. K.,
TroyerD. A.,
BearssD. J.other authors1998; A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol Cell Biol 18:85–92
BedalovA.,
GatbontonT.,
IrvineW. P.,
GottschlingD. E.,
SimonJ. A.2001; Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci U S A 98:15113–15118[CrossRef]
BrownA. J. P.2002; Morphogenetic signaling pathways in Candida albicans
. In Candida and Candidiasis pp 95–106 Edited by
CalderoneR. A.
Washington, DC: American Society for Microbiology;
ChiouC. Y.,
MalagodiM. H.1975; Studies on the mechanism of action of a new Ca2+ antagonist, 8-( N , N -diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol 53:279–285[CrossRef]
CotgreaveI. A.,
DuddyS. K.,
KassG. E. N.,
ThompsonD.,
MoldeusP.1989; Studies on the anti-inflammatory activity of ebselen: ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C. Biochem Pharmacol 38:649–656[CrossRef]
CoxD. A.,
ConfortiL.,
SperelakisN.,
MatlibM. A.1993; Selectivity of inhibition on Na+–Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. J Cardiovasc Pharmacol 21:595–599[CrossRef]
CruzM. C.,
GoldsteinA. L.,
BlankenshipJ.,
Del PoetaM.,
PerfectJ. R.,
McCuskerJ. H.,
BennaniY. L.,
CardenasM. E.,
HeitmanJ.2001; Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother 45:3162–3170[CrossRef]
DegterevA.,
LugovskyA.,
CardoneM.,
MulleyB.,
WagnerG.,
MitchisonT.,
YuanJ.2001; Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-XL. Nat Cell Biol 3:173–182[CrossRef]
FedorovaN. D.,
BadgerJ. H.,
RobsonG. D.,
WortmanJ. R.,
NiermanW. C.2005; Comparative analysis of programmed cell death pathways in filamentous fungi. BMC Genomics 6:177–191[CrossRef]
GarvinJ. L.,
SimonS. A.,
CragoeE. J. J.,
MandelL. J.1985; Phenamil: an irreversible inhibitor of sodium channels in the toad urinary bladder. J Membr Biol 87:45–54[CrossRef]
GietzenK.,
SadorfI.,
BaderH.1982; A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors. Biochem J 207:541–548
GrosmanN.1991; Effects of the ether phospholipid AMG-PC on mast cells are similar to that of the ether lipid AMG but different from that of the analogue hexadecylphosphocholine. Immunopharmacology 22:39–47[CrossRef]
GuiraudP.,
SteimanR.,
Campos-TakakiG. M.,
Seigle-MurandiF.,
Simeon de BuochbergM.1994; Comparison of antibacterial and antifungal activities of lapachol and β -lapachone. Planta Med 60:373–374[CrossRef]
HamaguchiT.,
SudoT.,
OsadaH.1995; RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1 phase. FEBS Lett 372:54–58[CrossRef]
HaraM.,
AkasakaK.,
AkinagaS.,
OkabeM.,
NakanoH.,
GomezR.,
WoodD.,
UhM.,
TamanoiF.1993; Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci U S A 90:2281–2285[CrossRef]
HerbertJ. M.,
AugereauJ. M.,
GleyeJ.,
MaffrandJ. P.1990; Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993–999[CrossRef]
HobergK. A.,
CihlarR. L.,
CalderoneR. A.1983; Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans
. Antimicrob Agents Chemother 24:401–408[CrossRef]
KaseH.,
IwahashiK.,
NakanishiS.,
MatsudaY.,
YamadaK.,
TakahashiM.,
MurakataC.,
SatoA.,
KanekoM.1987; K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142:436–440[CrossRef]
KawamotoS.,
HidakaH.1984; 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun 125:258–264[CrossRef]
KlausnerR. D.,
DonaldsonJ. G.,
Lippincott-SchwartzJ.1992; Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116:1071–1080[CrossRef]
LackeyK.,
CoryM.,
DavisR.,
FryeS. V.,
HarrisP. A.,
HunterR. N.,
JungD. K.,
McDonaldO. B.,
McNuttR. W.other authors2000; The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 10:223–226[CrossRef]
LebererE.,
HarcusD.,
DignardD.,
JohnsonL.,
UshinskyS.,
ThomasD. Y.,
SchroppelK.2001; Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans
. Mol Microbiol 42:673–687
LeesnitzerL. M.,
ParksD. J.,
BledsoeR. K.,
CobbJ. E.,
CollinsJ. L.,
ConslerT. G.,
DavisR. G.,
Hull-RydeE. A.,
LenhardJ. M.other authors2002; Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640–6650[CrossRef]
MaidanM. M.,
De RopL.,
SerneelsJ.,
ExlerS.,
RuppS.,
TournuH.,
TheveleinJ. M.,
Van DijckP.2005; The G protein-coupled receptor Gpr1 and the G α protein Gpa2 act through the cAMP-protein kinase A pathway to induce morphogenesis in Candida albicans
. Mol Biol Cell 16:1971–1986[CrossRef]
MassillonD.,
StalmansW.,
van de WerveG.,
BollenM.1994; Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor. Biochem J 299:123–128
McKennaJ. P.,
HansonP. J.1993; Inhibition by Ro 31-8220 of acid secretory activity induced by carbachol indicates a stimulatory role for protein kinase C in the action of muscarinic agonists on isolated rat parietal cells. Biochem Pharmacol 46:583–588[CrossRef]
MerrittJ. E.,
ArmstrongW. P.,
BenhamC. D.,
HallamT. J.,
JacobR.,
Jaxa-ChamiecA.,
LeighB. K.,
McCarthyS. A.,
MooresK. E.,
RinkT. J.1990; SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271:515–522
MiwaT.,
TakagiY.,
ShinozakiM.,
YunC.-W.,
SchellW. A.,
PerfectJ. R.,
KumagaiH.,
TamakiH.2004; Gpr1, a putative G-protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicans
. Eukaryot Cell 3:919–931[CrossRef]
NatarajanK.,
SinghS.,
BurkeT. R.,
GrunbergerD.,
AggarwalB. B.1996; Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF- κ B. Proc Natl Acad Sci U S A 93:9090–9095[CrossRef]
NehilM. T.,
TambleC. M.,
CombsD. J.,
KelloggD. R.,
LokeyR. S.2007; Uncovering genetic relationships using small molecules that selectively target yeast cell cycle mutants. Chem Biol Drug Des 69:258–264[CrossRef]
NoverrM. C.,
Erb-DownwardJ. R.,
HuffnagleG. B.2003; Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 16:517–533[CrossRef]
PhanQ. T.,
BelangerP. H.,
FillerS. G.2000; Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68:3485–3490[CrossRef]
PierceJ. W.,
SchoenleberR.,
JesmokG.,
BestJ.,
MooreS. A.,
CollinsT.,
GerritsenM. E.1997; Novel inhibitors of cytokine-induced IkBa phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
. J Biol Chem 272:21096–21103[CrossRef]
PowersJ. C.,
KamC. M.,
NarasimhanL.,
OleksyszynJ.,
HernandezM. A.,
UedaT.1989; Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design. J Cell Biochem 39:33–46[CrossRef]
RaoG. H.1987; Influence of calmodulin antagonist (stelazine) on agonist-induced calcium mobilization and platelet activation. Biochem Biophys Res Commun 148:768–775[CrossRef]
SalariH.,
BraquetP.,
BorgeatP.1984; Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med 13:53–60[CrossRef]
SavilleS. P.,
LazzellA. L.,
MonteagudoC.,
Lopez-RibotJ. L.2003; Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2:1053–1060[CrossRef]
Schmidt-WesthausenA.,
SchillerR. A.,
PohleH. D.,
ReichartP. A.1991; Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy. J Oral Pathol Med 20:467–472
SmithR. J.,
SamL. M.,
JustenJ. M.,
BundyG. L.,
BalaG. A.,
BleasdaleJ. E.1990; Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther 253:688–697
StuehrD. J.,
FasehunO. A.,
KwonN. S.,
GrossS. S.,
GonzalezJ. A.,
LeviR.,
NathanC. F.1991; Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5:98–103
TamaokiT.,
NomotoH.,
TakahashiI.,
KatoY.,
MorimotoM.,
TomitaF.1986; Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135:397–402[CrossRef]
ToenjesK. A.,
MunseeS. M.,
IbrahimA. S.,
JeffreyR.,
EdwardsJ. E.Jr,
JohnsonD. I.2005; Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans
. Antimicrob Agents Chemother 49:963–972[CrossRef]
VercesiA. E.,
MorenoS. N. J.,
BernardesC. F.,
MeinickeA. R.,
FernandesE. C.,
DocampoR.1993; Thapsigargin causes Ca2+ release and collapse of the membrane potential of Trypanosoma brucei mitochondria in situ and of isolated rat liver mitochondria. J Biol Chem 268:8564–8568
VigushinD. M.,
MirsaidiN.,
BrookeG.,
SunC.,
PaceP.,
InmanL.,
MoodyC. J.,
CoombesR. C.2004; Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo. Med Oncol 21:21–30[CrossRef]
WallaceK. K.,
ReynoldsK. A.,
KochK.,
McArthurH. A. I.,
BrownM. S.,
WaxR. G.,
MooreB. S.1994; Biosynthetic studies of ascomycin (FK520): formation of the (1R,3R,4R)-3,4-dihydroxycyclohexanecarboxylic acid-derived moiety. J Am Chem Soc 116:11600–11601[CrossRef]
WangG.,
LemosJ. R.1992; Tetrandrine blocks a slow, large-conductance, Ca2+-activated potassium channel besides inhibiting a non-inactivating Ca2+ current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch 421:558–565[CrossRef]
WhitesellL.,
MimnaughE. G.,
De CostaB.,
MyersC. E.,
NeckersL. M.1994; Inhibition of heat shock protein HSP90–pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A 91:8324–8328[CrossRef]
WykleR. L.,
MillerC. H.,
LewisJ. C.,
SchmittJ. D.,
SmithJ. A.,
SurlesJ. R.,
PiantadosiC.,
O'FlahertyJ. T.1981; Stereospecific activity of 1- O -alkyl-2- O -acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. Biochem Biophys Res Commun 100:1651–1658[CrossRef]
YatomiY.,
RuanF.,
MegidishT.,
ToyokuniT.,
HakomoriS.,
IgarashiY.1996; N , N -dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 35:626–633[CrossRef]
ZhengB.,
OishiK.,
ShojiM.,
EiblH.,
BerdelW. E.,
HajduJ.,
VoglerW. R.,
KuoJ. F.1990; Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphate, and sodium pump by synthetic phospholipid analogues. Cancer Res 50:3025–3031
ZinckR.,
CahillM. A.,
KrachtM.,
SachsenmaierC.,
HipskindR. A.,
NordheimA.1995; Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 15:4930–4938